On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

420 with CNW – FDA Calls for Public Comments on Marijuana

The U.S. Food and Drug Administration has announced that members of the public and the scientific community have an opportunity to share their thoughts on several substances, including marijuana. Of specific interest is the medical usefulness, abuse potential and actual abuse of the listed substances (including cannabis).

The FDA action comes at a time when the World Health Organization (WHO) is planning to meet in November this year to review the scheduling of cannabis. The ECDD (Expert Committee on Drug Dependence) is the body that will decide whether marijuana should stay as a schedule 1 substance or that categorization should be changed.

Schedule 1 substances are substances which are regarded as having no medical value yet they possess a high risk of being abused. The UN and the U.S. currently categorize marijuana as a schedule 1 substance.

The outcome of the ECDD meeting will influence how many of the UN member states regard cannabis going forward. However, the decision arrived at may or may not be disregarded by member states.

For example, Canada went ahead and legalized adult use of marijuana despite its categorization as a schedule 1 substance. Similarly, many countries around the world have legalized medical cannabis even if the UN looks at the substance as having no medical value.

The current count of U.S. states where medical cannabis is legal now stands at 31, and more are expected to vote for decriminalization during the coming mid-term elections.

Marijuana advocates should not start celebrating that the Trump administration is finally willing to listen and act on the views of the stakeholders of the marijuana industry.

The administration is bound by law to collect people’s views, but there is no compulsion for them to pay any attention to the voices which speak up during the hearings.

That notwithstanding, numerous groups, such as the Marijuana Policy Project, have collected and submitted lots of scientific and anecdotal data on the medicinal value of cannabis to the WHO committee. That same information will be forwarded to the FDA which has put an October 31 deadline on the submission of comments.

Of key interest is the matter of teen use of marijuana. The current data suggests that no increase in the number of teenagers using pot has been seen in the states where marijuana use is legal either for recreational or medical reasons. This should allay any fears that public health will be threatened by an explosion of teen stoners.

While marijuana advocates hope for the best from these hearings, they are also aware that a committee was secretly set up by the Trump administration to gather negative data about cannabis. Companies like Global Payout, Inc. (OTC: GOHE) and Golden Developing Solutions, Inc. (OTC: DVLP) keep wishing that regulators and legislators everywhere listen honestly and make decisions based on concrete data instead of relying on preconceived notions when making policy decisions.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office


Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 303.498.7722